Colorectal cancer is one of the most commonly diagnosed cancers and cause of cancer‐
related deaths worldwide. Studies have demonstrated that patient outcome is substantially …

Introduction: The increasing incidence of colorectal cancer (CRC) in young adults warrants
early and preferably noninvasive diagnostic modalities. Although the current stool-based …

Fecal occult blood test (FOBT) and flexible sigmoidoscopy are the currently using screening
methods for colorectal cancer (CRC). However, these methods still have problems of high …

Introduction: Cancer causes thousands of deaths worldwide each year. Therefore,
monitoring of health status and the early diagnosis of cancer using noninvasive assays …

PURPOSE: A number of urine based markers have been and are being investigated for the
diagnosis and prognostication of urological conditions. A majority of these markers have …

Serum carcinoembryonic antigen (CEA) and CA19‐9, a carbohydrate antigen recognized by
the monoclonal antibody NS19‐9, are commonly used as classical tumor markers in …

W hen it comes to sampling body fluids for cancer biomarkers, blood has traditionally been
the dominant choice. That's not surprising—as a biofluid, blood offers favorable …

The early detection of urological cancers is pivotal for successful patient treatment and
management. The development of molecular assays that can diagnose disease accurately …

Each year, more than 10 million people are diagnosed with cancer worldwide, while almost
8 million die from cancer or cancer-associated diseases and 12% of all deaths globally are …

Colorectal cancer (CRC) is a global problem affecting millions of people worldwide. This
disease is unique because of its slow progress that makes it preventable and often curable …